Month: April 2021

First-quarter 2021 revenue expected to be more than $1.1 million Net cash used for the first quarter 2021 of approximately $4.1 millionROCKAWAY, NJ, April 13, 2021 (GLOBE NEWSWIRE) —  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the first quarter of 2021. “We are pleased to announce a return to strong sequential revenue growth in the first quarter of 2021,” stated Dan Goldberger, Chief Executive Officer of electroCore. In addition to strong performances in the United States and the United Kingdom, our new OUS distributor relationships have begun generating revenue with initial orders totaling approximately $45,000 from Eastern Europe and Australia, and initial revenue from our...

ASHBURN, Va., April 13, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced its Xacta® solution will be available to support all Microsoft Azure U.S. Government cloud instances, including Azure Government, Azure Government Secret and Azure Government Top Secret. “Microsoft has been a tremendous partner,” said John B. Wood, CEO and chairman, Telos. “From the very beginning we have had a shared vision for streamlining the risk management and compliance process, and together we’ll begin to considerably reduce the time and cost it takes to receive and maintain authorizations.” Currently available on the Azure Marketplace, Xacta is specifically engineered for compliance of systems and networks...

BOWIE, Md., April 13, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has augmented its 2020 Annual Report with the provision of its inaugural Sustainability Report for the period which includes the Company’s environmental, social and governance (ESG) priorities. The report highlights the Company’s mission to enable a more efficient healthcare ecosystem that benefits individuals, society as a whole, and the environment. “At the very core of our mission is the provision of capabilities that empower greater efficiency and impact across the healthcare ecosystem,” said Keith Dunleavy, M.D., chief executive officer of Inovalon. “Not only is our work dedicated to the improvement of care and its sustainability for hundreds of millions...

ROCHESTER, Mich. , April 13, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received the ranking of #277 by the Financial Times (FT) list of The Americas’ Fastest Growing Companies 2021. This recognition is presented by the FT and Statista Inc., the world-leading statistics portal and industry ranking provider. The FT Americas’ Fastest Growing Companies list ranks companies with the strongest compounded annual revenue growth between 2016 and 2019. OptimizeRx grew more than 46% during that period, showing its strongest growth to date in 2020 with full year revenue up 76% year-over-year. Out of the millions of active companies in North and South America, only the top 500 firms are named to the list. “We are thrilled to...

WYOMISSING, Pa., April 13, 2021 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or “the Company”) announced today that it entered into a binding term sheet with Bally’s Corporation (NYSE: BALY) (“Bally’s”) to acquire the real estate assets of Bally’s casino property in Black Hawk, CO and the property it plans to acquire in Rock Island, IL, in a transaction which is subject to regulatory approval and expected to close later this year. Total consideration for the acquisition is $150 million. The parties expect to add the properties to the master lease they are entering into in connection with Bally’s previously announced acquisitions of Tropicana Evansville and Dover Downs Hotel & Casino (“GLPI-BALY master lease”) which will generate incremental rent of $12.0 million. Normalized rent coverage...

LOS ANGELES, April 13, 2021 (GLOBE NEWSWIRE) — ePlay Digital Inc. (CSE:EPY | OTC:EPYFF | FSE:2NY2) today announced the release of its first game with App Central. The partnership has App Central spending more than $50,000 on marketing the first title as part of its hyper-casual mobile gaming bundle available from Apple App Store. New in-app subscription services have been created by ePlay, utilizing the App Central partnership. App Central is an Artificial Intelligence AI-powered publishing house, dedicated to ensure its partners’ apps will benefit from increased user value, along-side a growing active user base. ePlay’s Big Swish has been added to App Central’s Personal Trainer Pro Subscription Bundle in the Apple App Store. App bundles make it easy for customers to buy up to 10 apps or games in a single purchase or via an auto-renewable...

HIGH POINT, N.C., April 13, 2021 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for TTP399 as an adjunctive therapy to insulin for the treatment of type 1 diabetes. TTP399 is a novel, oral, investigational once-daily glucokinase activator. Breakthrough Therapy designation is based on FDA’s determination that preliminary clinical evidence indicates that an investigational therapy may demonstrate substantial improvement on one or more significant endpoints relative to available therapies for a serious or life-threatening condition. Once granted, Breakthrough Therapy designation...

PALO ALTO, Calif. and SACRAMENTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with the University of California, Davis (UC Davis), to advance research and the development of investigational medicines for patients with genetically driven conditions and cancers. “UC Davis is a top-tier research university and we feel honored to get the chance to collaborate closely with the talented team there as we work to discover, create, test and deliver breakthrough medicines for people who are suffering from genetic diseases,” said BridgeBio founder and CEO Neil Kumar, Ph.D. Under the agreement, the BridgeBio team will work closely with investigators at UC Davis to seek and evaluate potential research projects in genetic disease and precision oncology. “We have a great appreciation...

PALO ALTO, Calif. and BUFFALO, N.Y., April 13, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with Roswell Park Comprehensive Cancer Center to advance the development of investigational therapeutics for patients with genetically driven cancers. “We are honored to begin collaborating with Roswell Park, which is renowned for its excellence in cancer research and its mission to set the gold standard for treating patients with genetically driven cancers,” said BridgeBio CEO and founder Neil Kumar, Ph.D. Under the partnership, BridgeBio will work with scientists at Roswell Park Comprehensive Cancer Center to evaluate new research and development opportunities in oncology that have promise to advance and potentially provide clinical benefit for patients. Select therapeutic programs may be...